Fred Alger Management’s GeneDx Holdings WGS Stock Holding History

Fred Alger Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13M	Sell	202,771 -63,865	-24%	-$5.82M	0.06%	144
2025 Q4	$34.7M	Sell	266,636 -90,666	-25%	-$12.4M	0.14%	86
2025 Q3	$38.5M	Sell	357,302 -463,221	-56%	-$50.5M	0.15%	76
2025 Q2	$75.7M	Buy	820,523 +263,505	+47%	+$20.7M	0.34%	41
2025 Q1	$49.3M	Buy	557,018 +10,964	+2%	+$951K	0.28%	52
2024 Q4	$42M	Buy	546,054 +151,824	+39%	+$10.6M	0.2%	79
2024 Q3	$16.7M	Buy	+394,230	New	+$13.3M	0.08%	143

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ZDA

Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fred Alger Management's WGS Position: Q1 2026 in Review

Fred Alger Management reduced its GeneDx Holdings (WGS) stake by 24% in Q1 2026, selling an estimated $5.82M and leaving 202,771 shares worth $13M. The position accounts for 0.06% of the portfolio, ranked #144.

Fred Alger Management first reported a position in WGS in Q3 2024 and has held it in 7 quarters since. The position peaked at $75.7M in Q2 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

Fred Alger Management held 202,771 shares of GeneDx Holdings worth $13M as of Q1 2026.
Fred Alger Management sold 63,865 GeneDx Holdings shares in Q1 2026, an estimated $5.82M.
GeneDx Holdings made up 0.06% of Fred Alger Management's portfolio in Q1 2026, its #144 holding.
Fred Alger Management first reported a position in GeneDx Holdings in Q3 2024 and has held it in 7 quarters since.
Fred Alger Management's GeneDx Holdings position peaked at $75.7M in Q2 2025.
240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.